NCT05401331

Brief Summary

The use of masks is a necessity due to the current pandemic conditions. The aim of the study is to examine the effects of the use of masks during effort on dyspnea and fatigue with hemodynamic parameters.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable covid19

Timeline
Completed

Started Apr 2022

Shorter than P25 for not_applicable covid19

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2022

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

April 11, 2022

Completed
20 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 2, 2022

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2022

Completed
Last Updated

August 30, 2022

Status Verified

February 1, 2022

Enrollment Period

1 month

First QC Date

April 11, 2022

Last Update Submit

August 25, 2022

Conditions

Keywords

DyspneaMaskOxygen SaturationBlood PressureHeart RateExercise TestCOVİD-19

Outcome Measures

Primary Outcomes (4)

  • Measurement of blood pressure changes due to mask use

    Blood pressure reading with sphygmomanometer.

    The period in which each participant is evaluated by taking the outcome criterion is 30-60 minutes.

  • Evaluation of dyspnea score

    Dyspnea score was evaluated with the Modified Borg Scale. The Modified Borg Scale is a 0 to 10 numerical score used to measure dyspnea. 0 indicates minimum dyspnea and 10 indicates maximum dyspnea.

    The period in which each participant is evaluated by taking the outcome criterion is 30-60 minutes.

  • Evaluation of the degree of perceived fatigue

    The degree of perceived fatigue was evaluated with the Modified Borg Scale. The Modified Borg Scale was used to assess perceived difficulty. The Modified Borg Scale is a numerical score from 0 to 10. 0 means minimum difficulty and 10 means maximum difficulty.

    The period in which each participant is evaluated by taking the outcome criterion is 30-60 minutes.

  • Measurement of oxygen saturation and heart rate changes due to mask use

    Oxygen saturation and heart rate were recorded with a pulseoximetry device.

    The period in which each participant is evaluated by taking the outcome criterion is 30-60 minutes.

Study Arms (2)

Hemodynamic changes due to mask use

OTHER

Hemodynamic changes due to mask use

Device: TreadmilllOther: mask

Hemodynamic responses when we do not use masks

OTHER

Hemodynamic responses when we do not use masks

Device: Treadmilll

Interventions

Hemodynamic changes before and after treadmill use

Also known as: Saturation device, Sphygmomanometer
Hemodynamic changes due to mask useHemodynamic responses when we do not use masks
maskOTHER

mask

Hemodynamic changes due to mask use

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Volunteering to work,
  • To be healthy,
  • age range.

You may not qualify if:

  • Unstabil angina pectoris,
  • Atrial arrhythmia,
  • Uncontrollable asthma,
  • Pa02 \< 50 mmHg,
  • PaCO2\> 70mmHg,
  • Individuals with valve disease
  • Tachycardia, bradycardia,
  • Individuals with a resting systolic blood pressure of 200 mmHg
  • Smoking,
  • Presence of effective clinical conditions such as nasal deviation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Sciences

Istanbul, 00034, Turkey (Türkiye)

Location

MeSH Terms

Conditions

COVID-19Dyspnea

Interventions

SphygmomanometersMasks

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesRespiration DisordersSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic EquipmentEquipment and SuppliesSurgical AttireEquipment and Supplies, HospitalProtective DevicesPersonal Protective EquipmentSurgical EquipmentManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Gülşah Karabıyık

    Saglik Bilimleri Universitesi

    PRINCIPAL INVESTIGATOR
  • Ayşegül Tunç

    Saglik Bilimleri Universitesi

    PRINCIPAL INVESTIGATOR
  • Zeynep Tanrıverdi

    Saglik Bilimleri Universitesi

    PRINCIPAL INVESTIGATOR
  • Selen Öztürk

    Saglik Bilimleri Universitesi

    PRINCIPAL INVESTIGATOR
  • Fulya Senem Karaahmetoğlu

    Saglik Bilimleri Universitesi

    PRINCIPAL INVESTIGATOR
  • Halit Çınarka

    Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 11, 2022

First Posted

June 2, 2022

Study Start

April 1, 2022

Primary Completion

May 1, 2022

Study Completion

June 10, 2022

Last Updated

August 30, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations